XTLB
XTL Biopharmaceuticals
XTLB
XTLB
5 hedge funds and large institutions have $1.85M invested in XTL Biopharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 3 reducing their positions, and 0 closing their positions.
Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$1.67M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$1K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $1.67M | 1,111,962 | -37,924 | -3% |
|
2
Invesco
Atlanta,
Georgia
| $183K | 129,811 | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $1K | 363 | -1,341 | -79% |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $0 | 100 | -300 | -75% |
|
5
Morgan Stanley
New York
| $0 | 8 | +8 | New |
|